KPV vs BPC-157 + TB-500
KPV and BPC-157 + TB-500 are both studied in recovery research, but they are different classes of compound with different reported research applications.
✓ both US-made · third-party tested · batch COA on every order
Last updated August 25, 2026
How do KPV and BPC-157 + TB-500 differ?
KPV (Tripeptide alpha-MSH fragment) is catalogued under recovery & gut research; BPC-157 + TB-500 (Co-formulated two-peptide research blend) is catalogued under recovery & gut research. Verve lists 5 reported research applications for KPV and 5 for BPC-157 + TB-500. Both are made in the United States, screened by HPLC to a 99%+ purity standard, and shipped with a batch-level certificate of analysis.
| field | KPV | BPC-157 + TB-500 |
|---|---|---|
| compound class | Tripeptide alpha-MSH fragment | Co-formulated two-peptide research blend |
| research area | recovery & gut | recovery & gut |
| reported research applications | 5 listed | 5 listed |
| supplied as | single compound | co-formulated blend |
| catalog sizes | 10mg | 20mg |
| purity standard | 99%+ by HPLC | 99%+ by HPLC |
| manufactured | United States | United States |
| batch COA | published per lot | published per lot |
| endotoxin-tested option | available | available |
| co-formulated together in | not co-formulated | not co-formulated |
| price from | $93.49 | $171.49 |
| availability | in stock | in stock |
Prices and stock read live from the catalog. Both compounds are supplied strictly as reference materials for in-vitro laboratory research.
What is KPV and what is BPC-157 + TB-500?
KPV is classified as Tripeptide alpha-MSH fragment; BPC-157 + TB-500 as Co-formulated two-peptide research blend. Both profiles below cover scientific identity only — what the molecule is and which laboratory models it appears in. Verve supplies both strictly as in-vitro reference materials, and neither profile describes human or veterinary use.
KPV
Tripeptide alpha-MSH fragment
KPV is a tripeptide composed of lysine, valine, and proline, corresponding to the C-terminal fragment (residues 11–13) of alpha-melanocyte-stimulating hormone (alpha-MSH). It is the smallest sequence retained from that parent peptide and is widely used as a compact reference compound in cellular signaling research, where its short chain length makes it convenient for controlled in-vitro work.
full KPV profile →BPC-157 + TB-500
Co-formulated two-peptide research blend
BPC-157 + TB-500 is a co-formulated research blend that combines two of the most frequently cited reference peptides in tissue-repair literature, BPC-157 / TB-500, in a single vial. BPC-157 is a synthetic pentadecapeptide derived from a partial sequence identified in human gastric juice; TB-500 is a synthetic 43-amino-acid peptide corresponding to an active fragment of thymosin beta-4, a naturally-occurring actin-binding protein.
full BPC-157 + TB-500 profile →Which research models is each compound studied in?
KPV and BPC-157 + TB-500 both sit inside recovery & gut research, so their listed models share framing while differing in specifics. The table lists 5 reported research applications for KPV and 5 for BPC-157 + TB-500. Rows are per compound, not equivalences.
| KPV — reported research applications | BPC-157 + TB-500 — reported research applications |
|---|---|
| Inflammatory-signaling research models (NF-κB pathway studies) | Multi-compound tissue-repair research models |
| Cytokine-expression research in cultured cells | Cell-migration and wound-healing research |
| Melanocortin-receptor and alpha-MSH fragment research | Angiogenesis and vascular-signaling research |
| Epithelial and mucosal-barrier research models | Actin-regulation and cytoskeletal research |
| Structure–activity studies of short peptide fragments | Comparative research on blended versus single-peptide preparations |
Research contexts only. Both compounds are supplied for laboratory research use only, and no entry above describes an effect in humans or animals.
What sizes and prices does verve list for KPV and BPC-157 + TB-500?
KPV is listed from $93.49 and BPC-157 + TB-500 from $171.49. The table below is every catalog size verve currently lists for the two compounds, at single-vial prices before the automatic multi-compound discount. Sizes describe the vial format supplied to the laboratory, nothing more.
| compound | size listed | price | availability |
|---|---|---|---|
| KPV | 10mg | $93.49 | in stock |
| BPC-157 + TB-500 | 20mg | $171.49 | in stock |
Any 2 different compounds take 20% off, any 3 take 30% — applied automatically in the cart, no code. Orders placed Monday–Friday ship by 2pm CT, free over $100.
shop the compounds →Frequently asked questions about KPV and BPC-157 + TB-500
What is KPV?
KPV is a tripeptide (lysine-valine-proline) corresponding to the C-terminal fragment of alpha-MSH. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is KPV studied for in research?
In in-vitro and pre-clinical models it is used as a reference compound in inflammatory-signaling, cytokine-expression, and melanocortin-pathway research. Verve makes no claims about use in humans or animals.
What is BPC-157 + TB-500?
BPC-157 + TB-500 is a co-formulated research blend of two well-characterized reference peptides, BPC-157 / TB-500, supplied in one vial. Verve supplies it as a research compound for laboratory use only, not for human or veterinary use.
What is the BPC-157 / TB-500 blend studied for in research?
It is used in multi-compound cellular models covering tissue repair, cell migration, angiogenesis, and actin regulation, where both peptides are studied together. Verve makes no health claims.
related comparisons
verve products are sold for laboratory research and development purposes only and are not intended for human or veterinary use of any kind. statements on this site have not been evaluated by the FDA.